Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?


OverviewForecastRevenueFinancialsChart

Voyager Therapeutics Ownership Summary


Voyager Therapeutics is owned by 11.23% institutional investors, 15.07% insiders, and 73.70% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.49% of VYGR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Voyager Therapeutics shares.

VYGR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVoyager Therapeutics11.23%15.07%73.70%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.57M9.49%$21.49M
Blackrock5.31M9.30%$42.02M
Armistice capital3.50M5.96%$13.51M
Millennium management3.43M5.84%$13.23M
Vanguard group3.27M5.55%$12.84M
Vestal point capital, lp3.00M5.12%$11.59M
Opaleye management1.15M1.96%$4.44M
Erste asset management gmbh1.10M1.87%$4.24M
Geode capital management1.05M1.79%$4.05M
State street948.23K1.62%$3.66M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management1.15M0.58%$4.44M
Vestal point capital, lp3.00M0.32%$11.59M
Sphera funds management469.76K0.29%$1.81M
Diadema partners lp423.64K0.28%$1.64M
Armistice capital3.50M0.24%$13.51M
Birchview capital, lp74.92K0.16%$289.18K
Persistent asset partners107.09K0.15%$413.38K
Privium fund management b.v.120.00K0.10%$463.20K
Clarivest asset management102.82K0.08%$813.32K
Virtus fund advisers4.03K0.07%$22.85K

Top Buyers

HolderShares% AssetsChange
Millennium management3.43M0.01%1.55M
Vestal point capital, lp3.00M0.32%1.53M
Blackrock5.31M0.00%915.17K
Diadema partners lp423.64K0.28%423.64K
Two sigma investments, lp615.66K0.00%392.95K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---4.00M
Farallon capital management---715.00K
Great point partners---626.27K
Armistice capital3.50M0.24%-500.00K
Price t rowe associates inc /md/117.08K0.00%-404.57K

New Positions

HolderShares% AssetsChangeValue
Diadema partners lp423.64K0.28%423.64K$1.64M
Vanguard fiduciary trust298.32K0.00%298.32K$1.15M
Woodline partners lp193.98K0.00%193.98K$748.78K
Hudson bay capital management lp156.25K0.00%156.25K$603.13K
Persistent asset partners107.09K0.15%107.09K$413.38K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Capital performance advisors llp-16.00
Northwestern mutual wealth management-28.00
Richards, merrill & peterson-30.00
Lindbrook capital-75.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202655-56.35%6,590,568-80.47%110.34%27-43.75%13-71.11%
Dec 31, 202578-34.45%16,989,289-43.76%281.09%30-43.40%29-25.64%
Sep 30, 2025111-0.89%25,893,441-21.95%441.38%472.17%375.71%
Jun 30, 2025109-6.03%33,129,2617.64%562.03%45-2.17%33-21.43%
Mar 31, 2025116-12.12%34,619,8870.33%591.67%46-32.35%4216.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.71M3.10%-
Vanguard Total Stock Mkt Idx Inv1.67M2.77%-
iShares Russell 2000 ETF1.13M1.87%9.49K
Vanguard Institutional Extnd Mkt Idx Tr543.56K0.90%-
Vanguard Explorer Inv457.06K0.76%-
Fidelity Small Cap Index455.70K0.75%2.78K
iShares Russell 2000 Value ETF390.00K0.65%2.10K
BlackRock Health Sciences Opps Inv A371.16K0.61%-
iShares Biotechnology ETF345.49K0.57%2.18K
Federated Hermes MDT SCC Institutional270.35K0.50%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 02, 2026Sandrock Alfred President and CEOSell$44.55K
Feb 24, 2026Swartz Robin COO & CBOSell$24.35K
Feb 24, 2026Sandrock Alfred President and CEOSell$53.81K
Feb 24, 2026Jorgensen Nathan D. Chief Financial OfficerSell$17.60K
Feb 24, 2026Carter Todd Alfred Chief Scientific OfficerSell$15.69K

Insider Transactions Trends


DateBuySell
2026 Q2-1
2026 Q1-10
2025 Q4-1
2025 Q3-1
2025 Q2-2

VYGR Ownership FAQ


Who Owns Voyager Therapeutics?

Voyager Therapeutics shareholders are primarily institutional investors at 11.23%, followed by 15.07% insiders and 73.70% retail investors. The average institutional ownership in Voyager Therapeutics's industry, Biotech Stocks , is 35.75%, which Voyager Therapeutics falls below.

Who owns the most shares of Voyager Therapeutics?

Voyager Therapeutics’s largest shareholders are Blackrock funding, inc. /de (5.57M shares, 9.49%), Blackrock (5.31M shares, 9.30%), and Armistice capital (3.5M shares, 5.96%). Together, they hold 24.75% of Voyager Therapeutics’s total shares outstanding.

Does Blackrock own Voyager Therapeutics?

Yes, BlackRock owns 9.30% of Voyager Therapeutics, totaling 5.31M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.02M$. In the last quarter, BlackRock increased its holdings by 915.17K shares, a 20.81% change.

Who is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested?

Opaleye management is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.58% of its assets in 1.15M Voyager Therapeutics shares, valued at 4.44M$.

Who is the top mutual fund holder of Voyager Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Voyager Therapeutics shares, with 3.10% of its total shares outstanding invested in 1.71M Voyager Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools